Welcome to our dedicated page for Owens & Minor SEC filings (Ticker: OMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings associated with Owens & Minor, Inc. (historically NYSE: OMI) provide detailed documentation of the company’s transformation into Accendra Health, Inc. and its strategic focus on home-based care. Forms 8-K describe key events such as the entry into and completion of the Equity Purchase Agreement for the sale of the Products & Healthcare Services (P&HS) segment, the structure of the consideration received, and the company’s retained equity interest in the divested business. These filings also outline related credit facility amendments, receivables sale programs, and the release of certain subsidiaries from guarantees under term loan and note indentures.
Investors can use this filings page to access current and historical 8-K reports that explain material events, including transaction terms, transition services arrangements, and changes to executive compensation and retirement plans. The filings also document the name change from Owens & Minor, Inc. to Accendra Health, Inc. through Articles of Amendment and amended bylaws, and they state that the company expects its common stock to begin trading on the New York Stock Exchange under the ticker symbol ACH. These disclosures clarify how the legacy OMI symbol relates to the continuing entity.
Quarterly and annual reports (Forms 10-Q and 10-K, when accessed through EDGAR) provide more comprehensive information about the company’s segments, including the classification of the P&HS segment as discontinued operations and the description of continuing operations as primarily representing the Patient Direct segment and certain functional operations. They also include discussions of risk factors, capital structure, and accounting treatment of receivables sale arrangements.
On Stock Titan’s SEC filings page, users can review these documents as they are made available from EDGAR and take advantage of AI-powered tools that summarize complex disclosures. These tools can help highlight the implications of major transactions, the impact of the P&HS divestiture on the company’s financial statements, and the significance of the corporate name and ticker change for holders of the legacy OMI shares.
Dimensional Fund Advisors LP filed an amended Schedule 13G reporting beneficial ownership of 3,507,559 shares of Owens & Minor Inc common stock, representing 4.5% of the class as of 09/30/2025. Dimensional states these shares are owned by client Funds for which it serves as adviser or sub-adviser and disclaims beneficial ownership; the filing shows 3,428,992 shares with sole voting power and no shared voting or dispositive power reported. The filing affirms the holdings are in the ordinary course of business and not intended to influence control.
Owens & Minor, Inc. agreed to sell its Products & Healthcare Services business (O&M PHS LLC) to Dominion Healthcare Acquisition Corporation for $375,000,000 in cash, subject to customary adjustments for cash, indebtedness, net working capital and transaction expenses. As part of the transaction, Owens & Minor will receive non‑voting rollover interests in Purchaser Parent in exchange for certain company securities; those rollover interests pay 50% of distributions after Purchaser Parent has made aggregate distributions of $310 million until Owens & Minor receives $200 million, and 5% of distributions thereafter.
The Equity Purchase Agreement and a company press release are dated October 7, 2025. The filing states related SEC reports (Form 10‑K and Form 10‑Q for specified periods) and that the cover page XBRL tags are embedded in the Inline XBRL document.
Owens & Minor, Inc. agreed to sell its Products & Healthcare Services business (O&M PHS LLC) to Dominion Healthcare Acquisition Corporation for $375,000,000 in cash, subject to customary adjustments for cash, indebtedness, net working capital and transaction expenses. As part of the transaction, Owens & Minor will receive non‑voting rollover interests in Purchaser Parent in exchange for certain company securities; those rollover interests pay 50% of distributions after Purchaser Parent has made aggregate distributions of $310 million until Owens & Minor receives $200 million, and 5% of distributions thereafter.
The Equity Purchase Agreement and a company press release are dated October 7, 2025. The filing states related SEC reports (Form 10‑K and Form 10‑Q for specified periods) and that the cover page XBRL tags are embedded in the Inline XBRL document.
Owens & Minor insider transaction: Jonathan A. Leon, EVP & CFO of Owens & Minor (OMI), reported a transaction dated 09/23/2025 in which 4,265 shares of the company's common stock were disposed at a reported price of $5.40 per share. The filing states these shares were surrendered to the issuer to satisfy tax withholding obligations arising from the vesting of restricted stock. After the disposal, Mr. Leon is reported to beneficially own 218,522 shares directly. The Form 4 was signed by a power of attorney on 09/24/2025.
Owens & Minor, Inc. reports that its Executive Vice President and Chief Information Officer, Snehashish Sarkar, has resigned from the company. He notified Owens & Minor on September 15, 2025 that he will leave his role effective September 26, 2025 to pursue another opportunity.
Sarkar has served as Chief Information Officer since October 2022. The company notes that during his tenure he built a strong global information technology team that is described as well-prepared to continue supporting Owens & Minor’s strategic priorities after his departure.
Owens & Minor, Inc. reports that its Executive Vice President and Chief Information Officer, Snehashish Sarkar, has resigned from the company. He notified Owens & Minor on September 15, 2025 that he will leave his role effective September 26, 2025 to pursue another opportunity.
Sarkar has served as Chief Information Officer since October 2022. The company notes that during his tenure he built a strong global information technology team that is described as well-prepared to continue supporting Owens & Minor’s strategic priorities after his departure.
Coliseum Capital affiliates reported multiple open-market purchases of Owens & Minor, Inc. (OMI) common stock between 08/12/2025 and 08/14/2025. The filings show purchases of 720,000, 325,000 and 492,852 shares at weighted-average prices of $5.15, $5.46 and $5.31, respectively. After these transactions the reporting persons beneficially owned 13,100,807 shares in the aggregate, held indirectly through Coliseum Capital Partners, L.P. and a separate advisory account; footnotes state CCP directly owned 10,657,337 shares and the Separate Account 2,443,470 shares. No derivative securities were reported.
Owens & Minor reported consolidated results showing continuing operations revenue rose to $681.9 million for the quarter and $1.356 billion for the six months, up from $660.4 million and $1.298 billion a year earlier. Continuing operations produced an operating loss of $39.7 million for the quarter and a pre-tax loss of $84.9 million, after recording an $80 million transaction breakage fee and acquisition-related charges.
The company classified its Products & Healthcare Services (P&HS) segment as discontinued operations and held-for-sale, recognizing a $106.4 million goodwill impairment and a $649.1 million loss on classification, contributing to a quarterly net loss of $869.1 million and basic loss per share of $11.30. Total assets were $4.15 billion with total liabilities of $4.44 billion, resulting in a deficit equity of $281.0 million at June 30, 2025. The divestiture process is described as in the final stages.
Owens & Minor, Inc. announced that it issued a press release reporting its financial results for the second quarter and for the six months ended June 30, 2025, and posted an earnings presentation on its Investor Relations website. The company furnished the press release as Exhibit 99.1, the earnings presentation as Exhibit 99.2, and included an Inline XBRL cover page as Exhibit 104. The 8-K states these materials are furnished under Item 2.02 and Item 7.01 and explicitly notes they are not "filed" for purposes of Section 18 of the Exchange Act. The numeric results and supporting slides are contained in the attached exhibits and on the company website rather than in the body of this filing.